AAPL330.24-8.08 (-2.39%) ▼|ABBV287.95-0.89 (-0.31%) ▼|ABT110.01-0.15 (-0.14%) ▼|ACN254.59-6.35 (-2.43%) ▼|ADBE246.00-5.48 (-2.18%) ▼|AMAT384.07+9.54 (+2.55%) ▲|AMD491.31+24.47 (+5.24%) ▲|AMGN464.58-0.87 (-0.19%) ▼|AMT186.11-2.19 (-1.16%) ▼|AMZN247.84+2.21 (+0.90%) ▲|AVGO333.97+11.74 (+3.64%) ▲|AXP327.03-0.95 (-0.29%) ▼|BA175.18-0.23 (-0.13%) ▼|BAC49.73+0.16 (+0.31%) ▲|BKNG151.68-2.07 (-1.35%) ▼|BLK1,170.84+3.69 (+0.32%) ▲|BMY62.62-0.40 (-0.63%) ▼|BNY149.53+1.75 (+1.18%) ▲|BRK-B558.69+2.58 (+0.46%) ▲|C122.32-0.78 (-0.63%) ▼|CAT625.83+12.21 (+1.99%) ▲|CL96.05-1.38 (-1.42%) ▼|CMCSA23.85-0.02 (-0.08%) ▼|COF208.86-1.91 (-0.91%) ▼|COP144.54-2.30 (-1.57%) ▼|COST1,023.50-17.05 (-1.64%) ▼|CRM222.01-4.17 (-1.84%) ▼|CSCO103.14+1.53 (+1.50%) ▲|CVS89.70+1.19 (+1.34%) ▲|CVX225.78-1.99 (-0.87%) ▼|DE672.00+4.40 (+0.66%) ▲|DHR232.23+4.26 (+1.87%) ▲|DIS113.17+0.06 (+0.05%) ▲|DUK127.29-1.09 (-0.85%) ▼|EMR166.67+0.71 (+0.42%) ▲|FDX322.74+4.49 (+1.41%) ▲|GD376.77+3.31 (+0.89%) ▲|GE321.86+6.08 (+1.93%) ▲|GEV921.45+59.20 (+6.87%) ▲|GILD170.19-0.14 (-0.08%) ▼|GM88.93-1.01 (-1.12%) ▼|GOOG277.38-0.66 (-0.24%) ▼|GOOGL278.33-0.66 (-0.24%) ▼|GS900.23+1.51 (+0.17%) ▲|HD334.24-6.92 (-2.03%) ▼|HON225.01+1.24 (+0.55%) ▲|IBM249.64-2.88 (-1.14%) ▼|INTC61.06+1.09 (+1.82%) ▲|INTU347.68-4.42 (-1.26%) ▼|ISRG441.28+4.41 (+1.01%) ▲|JNJ269.86-0.70 (-0.26%) ▼|JPM337.47-3.12 (-0.91%) ▼|KO94.92-0.92 (-0.95%) ▼|LIN516.38-3.34 (-0.64%) ▼|LLY1,419.32+8.33 (+0.59%) ▲|LMT645.53+2.38 (+0.37%) ▲|LOW215.27-2.88 (-1.32%) ▼|LRCX232.03+4.47 (+1.96%) ▲|MA649.53-8.58 (-1.30%) ▼|MCD262.59-3.05 (-1.15%) ▼|MDLZ65.79-0.60 (-0.90%) ▼|MDT99.55+0.26 (+0.26%) ▲|META619.31+12.58 (+2.07%) ▲|MMM176.38-1.99 (-1.11%) ▼|MO76.82-0.35 (-0.45%) ▼|MRK145.27-3.10 (-2.09%) ▼|MS185.65-0.08 (-0.04%) ▼|MSFT515.41+8.29 (+1.63%) ▲|MU852.50+18.91 (+2.27%) ▲|NEE84.63-0.40 (-0.47%) ▼|NFLX62.55+0.21 (+0.33%) ▲|NKE38.50-0.62 (-1.59%) ▼|NOW108.39+2.38 (+2.25%) ▲|NVDA207.82+5.76 (+2.85%) ▲|ORCL125.22+6.00 (+5.03%) ▲|PEP138.41-2.02 (-1.44%) ▼|PFE30.48-0.19 (-0.62%) ▼|PG162.32-1.24 (-0.76%) ▼|PLTR171.92-6.43 (-3.60%) ▼|PM207.87-0.42 (-0.20%) ▼|QCOM163.69+1.61 (+0.99%) ▲|RTX205.10+2.31 (+1.14%) ▲|SBUX104.53+0.13 (+0.12%) ▲|SCHW89.20+0.49 (+0.55%) ▲|SO94.23-0.39 (-0.41%) ▼|SPG220.77-0.97 (-0.44%) ▼|T21.35-0.09 (-0.41%) ▼|TMO697.09+14.44 (+2.12%) ▲|TMUS157.33-2.82 (-1.76%) ▼|TSLA399.43-4.39 (-1.09%) ▼|TXN313.11+11.09 (+3.67%) ▲|UBER66.83+0.12 (+0.18%) ▲|UNH402.91+2.47 (+0.62%) ▲|UNP305.07-1.93 (-0.63%) ▼|UPS109.31-0.40 (-0.36%) ▼|USB60.25-0.24 (-0.40%) ▼|V423.04-2.48 (-0.58%) ▼|VZ45.16+0.11 (+0.23%) ▲|WFC85.26-0.63 (-0.73%) ▼|WMT125.62-2.07 (-1.62%) ▼|XOM177.33-2.35 (-1.31%) ▼|AAPL330.24-8.08 (-2.39%) ▼|ABBV287.95-0.89 (-0.31%) ▼|ABT110.01-0.15 (-0.14%) ▼|ACN254.59-6.35 (-2.43%) ▼|ADBE246.00-5.48 (-2.18%) ▼|AMAT384.07+9.54 (+2.55%) ▲|AMD491.31+24.47 (+5.24%) ▲|AMGN464.58-0.87 (-0.19%) ▼|AMT186.11-2.19 (-1.16%) ▼|AMZN247.84+2.21 (+0.90%) ▲|AVGO333.97+11.74 (+3.64%) ▲|AXP327.03-0.95 (-0.29%) ▼|BA175.18-0.23 (-0.13%) ▼|BAC49.73+0.16 (+0.31%) ▲|BKNG151.68-2.07 (-1.35%) ▼|BLK1,170.84+3.69 (+0.32%) ▲|BMY62.62-0.40 (-0.63%) ▼|BNY149.53+1.75 (+1.18%) ▲|BRK-B558.69+2.58 (+0.46%) ▲|C122.32-0.78 (-0.63%) ▼|CAT625.83+12.21 (+1.99%) ▲|CL96.05-1.38 (-1.42%) ▼|CMCSA23.85-0.02 (-0.08%) ▼|COF208.86-1.91 (-0.91%) ▼|COP144.54-2.30 (-1.57%) ▼|COST1,023.50-17.05 (-1.64%) ▼|CRM222.01-4.17 (-1.84%) ▼|CSCO103.14+1.53 (+1.50%) ▲|CVS89.70+1.19 (+1.34%) ▲|CVX225.78-1.99 (-0.87%) ▼|DE672.00+4.40 (+0.66%) ▲|DHR232.23+4.26 (+1.87%) ▲|DIS113.17+0.06 (+0.05%) ▲|DUK127.29-1.09 (-0.85%) ▼|EMR166.67+0.71 (+0.42%) ▲|FDX322.74+4.49 (+1.41%) ▲|GD376.77+3.31 (+0.89%) ▲|GE321.86+6.08 (+1.93%) ▲|GEV921.45+59.20 (+6.87%) ▲|GILD170.19-0.14 (-0.08%) ▼|GM88.93-1.01 (-1.12%) ▼|GOOG277.38-0.66 (-0.24%) ▼|GOOGL278.33-0.66 (-0.24%) ▼|GS900.23+1.51 (+0.17%) ▲|HD334.24-6.92 (-2.03%) ▼|HON225.01+1.24 (+0.55%) ▲|IBM249.64-2.88 (-1.14%) ▼|INTC61.06+1.09 (+1.82%) ▲|INTU347.68-4.42 (-1.26%) ▼|ISRG441.28+4.41 (+1.01%) ▲|JNJ269.86-0.70 (-0.26%) ▼|JPM337.47-3.12 (-0.91%) ▼|KO94.92-0.92 (-0.95%) ▼|LIN516.38-3.34 (-0.64%) ▼|LLY1,419.32+8.33 (+0.59%) ▲|LMT645.53+2.38 (+0.37%) ▲|LOW215.27-2.88 (-1.32%) ▼|LRCX232.03+4.47 (+1.96%) ▲|MA649.53-8.58 (-1.30%) ▼|MCD262.59-3.05 (-1.15%) ▼|MDLZ65.79-0.60 (-0.90%) ▼|MDT99.55+0.26 (+0.26%) ▲|META619.31+12.58 (+2.07%) ▲|MMM176.38-1.99 (-1.11%) ▼|MO76.82-0.35 (-0.45%) ▼|MRK145.27-3.10 (-2.09%) ▼|MS185.65-0.08 (-0.04%) ▼|MSFT515.41+8.29 (+1.63%) ▲|MU852.50+18.91 (+2.27%) ▲|NEE84.63-0.40 (-0.47%) ▼|NFLX62.55+0.21 (+0.33%) ▲|NKE38.50-0.62 (-1.59%) ▼|NOW108.39+2.38 (+2.25%) ▲|NVDA207.82+5.76 (+2.85%) ▲|ORCL125.22+6.00 (+5.03%) ▲|PEP138.41-2.02 (-1.44%) ▼|PFE30.48-0.19 (-0.62%) ▼|PG162.32-1.24 (-0.76%) ▼|PLTR171.92-6.43 (-3.60%) ▼|PM207.87-0.42 (-0.20%) ▼|QCOM163.69+1.61 (+0.99%) ▲|RTX205.10+2.31 (+1.14%) ▲|SBUX104.53+0.13 (+0.12%) ▲|SCHW89.20+0.49 (+0.55%) ▲|SO94.23-0.39 (-0.41%) ▼|SPG220.77-0.97 (-0.44%) ▼|T21.35-0.09 (-0.41%) ▼|TMO697.09+14.44 (+2.12%) ▲|TMUS157.33-2.82 (-1.76%) ▼|TSLA399.43-4.39 (-1.09%) ▼|TXN313.11+11.09 (+3.67%) ▲|UBER66.83+0.12 (+0.18%) ▲|UNH402.91+2.47 (+0.62%) ▲|UNP305.07-1.93 (-0.63%) ▼|UPS109.31-0.40 (-0.36%) ▼|USB60.25-0.24 (-0.40%) ▼|V423.04-2.48 (-0.58%) ▼|VZ45.16+0.11 (+0.23%) ▲|WFC85.26-0.63 (-0.73%) ▼|WMT125.62-2.07 (-1.62%) ▼|XOM177.33-2.35 (-1.31%) ▼|
16.7 C
New York
Tuesday, November 3, 2026

Tag: events

newsFORsourcecompanycontentinformationreleases1market

AMERICA’S TRUE SIGNING DAY GETS NATIONAL RECOGNITION IN MAJOR 250TH ANNIVERSARY EVENT

Ohio's Perry's Victory Memorial Hosts Declaration 250 Event PUT-IN-BAY, Ohio, July 30, 2025 /PRNewswire/ -- As the United States prepares to celebrate the 250th anniversary...

Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer’s Association International Conference (AAIC) 2025

TOKYO and CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the two-year real-world study in the U.S of lecanemab (generic name, product name: LEQEBMI®), an anti-Aβ protofibril* antibody, was presented at the Alzheimer's Association International Conference (AAIC) 2025, held in Toronto, Canada and virtually. Only lecanemab fights AD in two ways – targeting both amyloid plaque and protofibrils*, which can impact tau downstream.

Anime Market to Grow at a CAGR of 9.6% from 2025 to 2032 | SkyQuest Technology Consulting

The Anime market is anticipated to increase due to rapidly expanding international fanbase, especially among Gen Z and millennials. Increased accessibility through streaming platforms...

Anime Market to Grow at a CAGR of 9.6% from 2025 to 2032 | SkyQuest Technology Consulting

The Anime market is anticipated to increase due to rapidly expanding international fanbase, especially among Gen Z and millennials. Increased accessibility through streaming platforms...

OpenText to Showcase AI-Driven Threat Detection, Identity Security, and Application Protection at Black Hat USA 2025

WATERLOO, ON, July 30, 2025 /CNW/ -- OpenText™ (NASDAQ:OTEX), (TSX:OTEX) will join global cybersecurity leaders at Black Hat USA 2025 to showcase how organizations...

OpenText to Showcase AI-Driven Threat Detection, Identity Security, and Application Protection at Black Hat USA 2025

WATERLOO, ON, July 30, 2025 /PRNewswire/ -- OpenText™ (NASDAQ:OTEX), (TSX:OTEX) will join global cybersecurity leaders at Black Hat USA 2025 to showcase how organizations...

Vystar Introduces New RxAir-800 Replacement Cartridge Extended Life UV-C Bulb

New RxAir400 Pro UV-C bulb replacement cartridge provides 18,000 vs 9,000 hr. use.

Mohawk Industries reporta resultados del segundo trimestre 2025

CALHOUN, Georgia, July 30, 2025 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (NYSE: MHK) anunció hoy utilidades netas del segundo trimestre de 2025 por $ 147 millones y utilidades por acción ('EPS') de $ 2.34; las utilidades netas ajustadas fueron de $ 173 millones, y la EPS ajustada fue de $ 2.77. Las ventas netas del segundo trimestre de 2025 fueron de $2.8 mil millones, esencialmente sin cambios, según lo reportado y una disminución de 0.8% ajustada en base a los días constantes y tipos de cambio, en comparación con el año anterior. Durante el segundo trimestre de 2024, la empresa reportó ventas netas de $ 2.8 mil millones, utilidades netas de $ 157 millones y utilidades por acción de $ 2.46; las utilidades netas ajustadas fueron $ 192 millones, y la EPS ajustada fue $ 3.00.

FatPipe Reports First Quarter Fiscal Year 2026 Results

SALT LAKE CITY, July 30, 2025 /PRNewswire/ -- FatPipe, Inc. (NASDAQ: FATN) ("FatPipe" or the "Company"), a pioneer in enterprise-class, application-aware, secure software-defined wide area...

Fireweed Intersects Sulphide Mineralization at Boundary Zone Muon Targets

TSXV: FWZOTCQX: FWEDFFSE: M0G VANCOUVER, BC, July 30, 2025 /CNW/ - Fireweed Metals Corp. ("Fireweed" or the "Company") (TSXV: FWZ) (OTCQX: FWEDF) is pleased to report the...

OpenText and TELUS partner to deliver Canadian sovereign AI-powered solutions for government and business

WATERLOO, ON, July 30, 2025 /PRNewswire/ -- OpenText™ (NASDAQ: OTEX), (TSX: OTEX), the leading information management company, and TELUS, a world-leading communications technology company, today...

VIVAKOR UNLOCKS $59 MILLION IN DEBT REDUCTION AND IMPROVES PROFITABILITY WITH STRATEGIC SALE OF NON-CORE BUSINESS UNITS

Focusing on Higher Margin and Growth Opportunities

The Pankey Institute’s Annual Symposium to be Held September 18-20, 2025 in Palm Beach, Florida

This Year's Theme, "Harmony in Interdisciplinary Care: Blending Expertise," Celebrates True Collaboration in Patient-Centered Dentistry KEY BISCAYNE, Fla., July 30, 2025 /PRNewswire/ -- The Pankey...

Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin

– New patent enhances market position in Europe

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsEvents

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers